EurekaMag.com logo
+ Site Statistics
References:
53,214,146
Abstracts:
29,074,682
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

The molecular basis of inhibitor resistance in a mammalian mitochondrial cytochrome b mutant






Journal of Biological Chemistry 262(5): 2411-2414

The molecular basis of inhibitor resistance in a mammalian mitochondrial cytochrome b mutant

The mitochondrial gene for the cytochrome b of Complex III has been cloned from a mouse L-cell mutant with increased resistance to 2-n-heptyl-4-hydroxyquinoline-N-oxide and other inhibitors which block reactions at the b562 heme group. Nucleotide sequencing revealed that this gene contained a G:A transition on the coding strand at position 14,830. At the amino acid level, this mutation results in the substitution of an aspartic acid residue for a conserved glycine at position 231 of cytochrome b. Based upon current models for the secondary structure of cytochrome b, the altered amino acid lies in close proximity to one of the invariant histidine residues involved in binding the heme groups. Combining this result with the previous biochemical studies of this mutant, we hypothesize that the insertion of this highly charged side chain alters the conformation around the b562 heme group such that 2-n-heptyl-4-hydroxyquinoline-N-oxide and the other inhibitors of this group have reduced access to the inhibitor binding domain.

(PDF 0-2 workdays service: $29.90)

Accession: 006719830

PMID: 3818601



Related references

Molecular basis for resistance to myxothiazol mucidin strobilurin a and stigmatellin cytochrome b inhibitors acting at the center of the mitochondrial ubiquinol cytochrome c reductase in saccharomyces cerevisiae. Journal of Biological Chemistry 264(24): 14543-14548, 1989

Molecular basis for resistance to antimycin and diuron, Q-cycle inhibitors acting at the Qi site in the mitochondrial ubiquinol-cytochrome c reductase in Saccharomyces cerevisiae. Journal of Biological Chemistry 263(25): 12564-12570, 1988

Mitochondrial genetics of mammalian cells: a mouse antimycin-resistant mutant with a probable alteration of cytochrome b. Somatic Cell Genetics 9(2): 143-163, 1983

Mammalian mitochondrial mutants selected for resistance to the cytochrome b inhibitors HQNO or myxothiazol. Somatic Cell Genetics 9(6): 721-743, 1983

Molecular basis of resistance to cytochrome bc1 inhibitors. Fems Yeast Research 8(2): 183-192, 2007

Molecular basis for the polyamine-ompF porin interactions: inhibitor and mutant studies. Journal of Molecular Biology 297(4): 933-945, 2000

Molecular phylogeny of Veneridae (Bivalvia: Heteroconchia) on the basis of partial sequences of mitochondrial cytochrome oxidase I. Korean Journal of Malacology. December; 202: 171-180, 2004

Mammalian mitochondrial mutants selected for resistance to the cytochrome b inhibitors 2 n heptyl 4 hydroxy quinoline n oxide or myxothiazol. Somatic Cell Genetics 9(6): 721-744, 1983

Mitochondrial heredity of resistance to 3-(3,4-dichlorophenyl)-1,1-dimethylurea, an inhibitor of cytochrome b oxidation, in Saccharomyces cerevisiae. European Journal of Biochemistry 74(3): 521-526, 1977

Cytochrome b5-like hemoprotein of outer mitochondrial membrane; OM cytochrome b. I. Purification of OM cytochrome b from rat liver mitochondria and comparison of its molecular properties with those of cytochrome b5. Journal of Biochemistry 87(1): 63-71, 1980